Yi Larson

Insider Reports History

Entity
Individual
Location
C/O Rayzebio, Inc., 5505 Morehouse Drive, Suite 300, San Diego, CA
Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yi Larson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LianBio Chief Financial Officer Ordinary Shares 326K $539K $1.65 Mar 29, 2023 Direct
LianBio Chief Financial Officer Stock Option (Right to Buy) 464K Jan 20, 2023 Direct
Olema Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 23K Jun 14, 2024 Direct
RayzeBio, Inc. Director Employee Stock Option (right to buy) 0 Feb 26, 2024 Direct

Insider Reports Filed by Yi Larson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OLMA Olema Pharmaceuticals, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 3 $0 4 Feb 27, 2024 Director
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
LIAN LianBio Mar 29, 2023 1 $0 4 Mar 31, 2023 Chief Financial Officer
LIAN LianBio Jan 20, 2023 1 $0 4 Jan 24, 2023 Chief Financial Officer
OLMA Olema Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4/A Jun 27, 2022 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
LIAN LianBio Dec 1, 2021 1 $0 4 Dec 3, 2021 Chief Financial Officer
LIAN LianBio Oct 31, 2021 1 $0 4 Nov 1, 2021 Chief Financial Officer
LIAN LianBio Oct 29, 2021 0 $0 3 Oct 29, 2021 Chief Financial Officer
OLMA Olema Pharmaceuticals, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director